Research ArticleArticle
Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of “Truth”: Content, Face, and Construct Validity
Peter Tugwell, Maarten Boers, Maria-Antonietta D’Agostino, Dorcas Beaton, Annelies Boonen, Clifton O. Bingham III, Ernest Choy, Philip G. Conaghan, Maxime Dougados, Catia Duarte, Daniel E. Furst, Francis Guillemin, Laure Gossec, Turid Heiberg, Désirée M. van der Heijde, Sarah Hewlett, John R. Kirwan, Tore K. Kvien, Robert B. Landewé, Philip J. Mease, Mikkel Østergaard, Lee Simon, Jasvinder A. Singh, Vibeke Strand and George Wells
The Journal of Rheumatology April 2014, jrheum.131310; DOI: https://doi.org/10.3899/jrheum.131310
Peter Tugwell
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Maarten Boers
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Maria-Antonietta D’Agostino
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Dorcas Beaton
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Annelies Boonen
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Clifton O. Bingham III
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Ernest Choy
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Philip G. Conaghan
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Maxime Dougados
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Catia Duarte
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Daniel E. Furst
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Francis Guillemin
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Laure Gossec
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Turid Heiberg
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Désirée M. van der Heijde
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Sarah Hewlett
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
John R. Kirwan
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Tore K. Kvien
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Robert B. Landewé
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Philip J. Mease
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Mikkel Østergaard
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Lee Simon
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Jasvinder A. Singh
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
Vibeke Strand
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
George Wells
From the Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California, USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo, Norway; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen, The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. P. Tugwell, MD, Department of Medicine, University of Ottawa; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; M-A. D’Agostino, MD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; E. Choy, MD, Section of Rheumatology, Cardiff University School of Medicine; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Division of Musculoskeletal Disease, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit; C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra; D.E. Furst, MD, Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC; L. Gossec, MD, PhD, UPMC — Paris 6, GRC-UMPC 08 (EEMOIS), AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; T. Heiberg, RN, PhD, Oslo University Hospital and Lovisenberg Diaconal University College; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; S. Hewlett, PhD, RN, University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary; J.R. Kirwan, MD, University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; T.K. Kvien, MD, Department of Rheumatology, Diakonhjemmet Hospital; R.B. Landewé, MD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen; P.J. Mease, MD, Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine; M. Østergaard, MD, DMSc, Department of Rheumatology, Copenhagen University Hospital at Glostrup; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical center; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.A. Wells, PhD, MSc, Director, Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa. Address correspondence to Dr. P. Tugwell, University of Ottawa, Centre for Global Health, 1 Stewart Street, Room 312, Institute of Population Health, Ottawa, Ontario K1N 6N5, Canada. E-mail: tugwell.bb@uottawa.ca
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of “Truth”: Content, Face, and Construct Validity
Peter Tugwell, Maarten Boers, Maria-Antonietta D’Agostino, Dorcas Beaton, Annelies Boonen, Clifton O. Bingham, Ernest Choy, Philip G. Conaghan, Maxime Dougados, Catia Duarte, Daniel E. Furst, Francis Guillemin, Laure Gossec, Turid Heiberg, Désirée M. van der Heijde, Sarah Hewlett, John R. Kirwan, Tore K. Kvien, Robert B. Landewé, Philip J. Mease, Mikkel Østergaard, Lee Simon, Jasvinder A. Singh, Vibeke Strand, George Wells
The Journal of Rheumatology Apr 2014, jrheum.131310; DOI: 10.3899/jrheum.131310
Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of “Truth”: Content, Face, and Construct Validity
Peter Tugwell, Maarten Boers, Maria-Antonietta D’Agostino, Dorcas Beaton, Annelies Boonen, Clifton O. Bingham, Ernest Choy, Philip G. Conaghan, Maxime Dougados, Catia Duarte, Daniel E. Furst, Francis Guillemin, Laure Gossec, Turid Heiberg, Désirée M. van der Heijde, Sarah Hewlett, John R. Kirwan, Tore K. Kvien, Robert B. Landewé, Philip J. Mease, Mikkel Østergaard, Lee Simon, Jasvinder A. Singh, Vibeke Strand, George Wells
The Journal of Rheumatology Apr 2014, jrheum.131310; DOI: 10.3899/jrheum.131310